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Abstract
Background: Prevention of mother-to-child transmission of HIV (PMTCT) programs collect socio-demographic and
HIV testing information similar to that collected by unlinked anonymous testing sero-surveillance (UAT) in antenatal
settings. Zimbabwe evaluated the utility of PMTCT data in replacing UAT.
Methods: A UAT dataset was created by capturing socio-demographic, testing practices from the woman’s
booking-card and testing remnant blood at a laboratory from 1 June to 30 September 2012. PMTCT data were
collected retrospectively from ANC registers. UAT and PMTCT data were linked by bar-code labels that were
temporarily affixed to the ANC register. A questionnaire was used to obtain facility-level data at 53 sites.
Results: Pooled HIV prevalence was 15.8 % (95 % CI 15.3–16.4) among 17,349 women sampled by UAT, and 16.3 %
(95 % CI 15.8 %–16.9 %) among 17,150 women in PMTCT datasets for 53 sites. Pooled national percent-positive
agreement (PPA) was 91.2 %, and percent-negative agreement (PNA) was 98.7 % for 16,782 women with matched
UAT and PMTCT data. Based on UAT methods, overall median prevalence was 12.9 % (Range 4.0 %–19.4 %) among
acceptors and refusers of HIV test in PMTCT compared to 12.5 % ((Range 3.4 %–19.5 %) among acceptors in ANC
registers. There were variations in prevalence by site.
Conclusion: Although, there is no statistical difference between pooled HIV prevalence in UAT compared to PMTCT
program, the overall PPA of 91.2 % and PNA of 98.7 % fall below World Health Organisation (WHO) benchmarks of
97.6 % and 99.6 % respectively. Zimbabwe will need to strengthen quality assurance (QA) of rapid HIV testing and
data collection practices. Sites with good performance should be prioritised for transitioning.
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Background
Over the past two decades, unlinked and anonymous HIV
testing (UAT) for surveillance among pregnant women
who routinely attend antenatal clinical (ANC) sentinel
sites has provided valuable information about the burden
of HIV and trends in HIV prevalence. Antenatal clinics
provide an accessible cross-section of healthy, sexually ac-
tive women in the general population, and HIV data from
ANC surveillance are considered generally representative
of the source community [1]. Epidemiologic information
provided by ANC surveillance addresses key aspects of
the “Know Your Epidemic” updated approach of second
generation surveillance of HIV, understanding changes in
the direction of the epidemic, understanding sub-national
variations in an epidemic and identifying localized geo-
graphic areas with higher burdens of HIV [2]. This infor-
mation is crucial for planning HIV control interventions
and allocating required resources. ANC surveillance data
also serve as one of the data sources used to construct
mathematical models of HIV prevalence and incidence
trends using Estimation and Projection Package (EPP)/
Spectrum analysis tools developed by the Joint United
Nations Programme on HIV/AIDS (UNAIDS) [3].
Globally, the scale-up of HIV care and treatment pro-
grams such as Prevention of Mother to Child Transmis-
sion (PMTCT) has highlighted the need to provide HIV
test results in all settings, including surveillance, in order
to increase access to care. Using the UAT methods, tests
are conducted on left-over blood from routine testing at
ANC (usually syphilis testing) where all personal identi-
fiers are removed and therefore results are not returned
to individuals. This approach has the potential to elimin-
ate selection bias due to non-consent because, when
testing is based on informed consent, individuals refus-
ing testing may be at lower or higher risk of HIV infec-
tion than consenters [4–6]. There are, however, ethical
concerns around using the UAT methods in conducting
ANC HIV sentinel sero-surveillance (ANC HSS). This
method does not obtain informed consent from preg-
nant women and therefore cannot return HIV testing re-
sults, or link HIV positive cases to HIV care, treatment,
and prevention interventions, [7, 8]. In recent years
there has been a growing global consensus around the
imperative to routinely provide HIV test results to par-
ticipants in HIV surveillance [9–11]. This has necessi-
tated a change in surveillance data collection methods
so that pregnant women can provide informed consent
for accepting or declining an HIV test, receive the re-
sults in post-test counselling and accept referral into
HIV care and treatment services during routine ante-
natal visits [2]
PMTCT programs collect socio-demographic and HIV
testing information similar to that collected by ANC
HSS hence, many countries are considering the use of
PMTCT program data to complement or replace UAT
surveillance. High-quality PMTCT program data could
provide an efficient and cost-effective alternative to UAT
surveillance and enhance data use among health care
workers.
The World Health Organisation (WHO) has provided
guidelines to assess PMTCT programs data and quality in
preparation of using PMTCT program data in replacing
UAT surveillance [2]. Core elements to be assessed
include: selection bias inherent in PMTCT-based HIV
estimates, the coverage of PMTCT HIV testing services at
sentinel sites, availability and completeness of a minimum
set of surveillance variables in routine program records,
accuracy of routine PMTCT HIV testing, and HIV testing
quality assurance practices at ANC sites.
Since 2002, Zimbabwe has used biannual UAT at 19
sentinel sites to track trends in HIV prevalence [12]. All
women accessing antenatal services in Zimbabwe are
also offered PMTCT intervention using the opt-out of
HIV testing strategy. As a result of the programmatic
shift and scale up, Zimbabwe has considered transition-
ing to using PMTCT data to monitor trends in the HIV
epidemic. The 2009 national ANC report highlighted
shortfalls in data quality in the PMTCT registers. The
report recommended revisions to the registers as well as
focused health workers training on how to capture key
indicators before transitioning to PMTCT program data
for surveillance.
Following key interventions such as revisions to regis-
ters and training in record keeping training in rapid HIV
testing and the scale up of the PMTCT program, we
conducted a comprehensive assessment of the utility of
PMTCT program data for ANC based surveillance in
2012. The overall objective was to assess the Zimbabwe
Ministry of Health and Child Care (MOHCC) PMTCT
programme’s readiness to use routine data for ANC
based surveillance. We compared UAT surveillance HIV
test results and prevalence estimates to those obtained
from PMTCT programme in the same time period,
assessed the completeness and quality of routine
PMTCT programme data, as well as health facility test-
ing and data recording practices.
Methods
The assessment of the utility of using PMTCT program
data for surveillance among pregnant women was
implemented in three parts: (1) a comparison of HIV
test results and prevalence estimates from UAT surveil-
lance and routine PMTCT HIV testing during the same
time period; (2) a retrospective data quality assessment
of routine ANC records during the UAT surveillance
period; (3) a health facility assessment to capture
information on PMTCT HIV testing and data record-
ing practices.
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Study sites and sample size
The sampling unit for this assessment was a sentinel site
providing PMTCT HIV testing services. Of the initial
target of 54 sentinel sites, 53 sites were included in the
2012 UAT surveillance and the PMTCT utility assess-
ment. UAT forms from one site Karoi did not have the
PMTCT results or samples for UAT testing and there-
fore a decision was made to exclude the site from ana-
lysis. Sites were chosen to represent all 8 provincial
regions and 2 major cities in Zimbabwe.
The UAT surveillance sample size requirement was 340
each for all sentinel sites with the exception of large city
health facilities, Kuwadzana, Nkulumane and St. Mary’s
where the sample size requirement was 600. Detailed
methods for sample size calculation for UAT are presented
in the full MOHCC report [13].The PMTCT data quality
assessment retrospectively collected data from all eligible
women in the ANC register during the same period in
which the UAT was conducted at all participating sites.
Data collection tools and methods
UAT prospective surveillance
Between June and September 2012 the UAT survey pro-
spectively enrolled women attending an ANC for the first
time during the current pregnancy until the required sam-
ples size for the site was achieved. The attending nurse or
midwife completed the UAT surveillance data collection
form for each eligible woman by abstracting information
from the mother’s booking card and ANC registers.
Firstly, all pregnant women were offered the routine
antenatal clinic tests which included syphilis testing and
blood grouping. Each woman who consented to routine
ANC tests had 5 ml of blood drawn for routine ANC
tests. The remnant blood sample was transferred into a
separate anticoagulant tube for UAT surveillance. This
blood was used to prepare Dried Blood Spots (DBS) on
Whatman’s filter paper. Bar code labelled stickers were
placed on the tube, DBS card and UAT surveillance
form. UAT specimens were recorded on a tally sheet and
transported to the National Microbiology Reference
Laboratory (NMRL) via courier service for Syphilis
confirmatory testing TPHA, and HIV testing using
Enzyme Immuno-Assay (EIA) test kits. The initial test
for HIV detection was conducted using AniLabsytems
(AniLabsystems Ltd, Finland). All non-reactive result
were reported negative as final result, while a reactive
result was confirmed using Enzygnost Anti HIV 1/2 plus
ELISA (Siemens Healthcare products, Munich Germany).
Non-reactive samples by Enzygnost Anti HIV1/2 plus
ELISA were further confirmed by Western Blot, New Lav
Blot 1 (Biorad, France). Indeterminate Western blot re-
sults were further tested by HIV DNA, PCR (ROCHE
Diagnostics, France). The laboratory provided dataset
with a final HIV result that was used in analysis. Results
of NMRL testing were double entered into a database
and sent, with UAT surveillance data collection forms,
to the AIDS and TB Unit.
All pregnant women attending antenatal care were also
offered HIV testing and counselling in ANC services and
those who accepted received their results on the same visit
day during post-test counseling. The HIV screening test
was done using a Determine test kit. If the result was non-
reactive, the woman was considered HIV-negative; a react-
ive test was confirmed using SD-Bioline and discrepant
results were tested using INSTI™ HIV-1 Antibody test as a
tiebreaker. All HIV results were recorded on the woman’s
ANC booking card and in the ANC register. For this as-
sessment, results of the rapid HIV test were entered from
the register onto the UAT surveillance form that accom-
panied the UAT surveillance DBS, which was sent to the
NMRL for UAT testing.
PMTCT retrospective data quality assessment
Health Information officers were assigned to retrospect-
ively abstract PMTCT program data from the ANC
register at the sentinel sites for the period June to
September 2012, the same period in which the UAT sur-
veillance was conducted at the 53 sites. During the UAT
survey period, the site nurse affixed an extra bar code
label in the ANC register for all women accepting
PMTCT HIV testing and those who were not tested be-
cause they were either on ART or self –reported their
status as HIV positive. The bar-code allowed us to con-
duct a head to head comparison of the UAT surveillance
dataset and ANC register data. The key variables cap-
tured by the UAT surveillance form and also captured
from the ANC registers included (1) demographic infor-
mation (age, marital status, usual residence and educa-
tional level of client); (2) medical information (presence
and history of sexually transmitted infections); (3) ob-
stetric history (gravidity and parity) and (4) PMTCT-
related information (HIV status at booking, offer and
acceptance of PMTCT HIV testing at the current visit,
current HIV test result, and whether the woman was
currently on antiretroviral medication). The bar-codes in
the ANC registers were removed from the registers
when data abstraction and preliminary analysis of HIV
test results from the NMRL was completed. The bar
code allowed linkage of UAT results to PMTCT pro-
gram data which had personal identifiable information.
Realizing this, the MOHCC took action by returning to
all sites and delinking the data by removing the bar
codes affixed to the registers. This was reported to the
Medical Research Council of Zimbabwe and permission
was sought to follow up on the initially 14 women who
were supposed to be HIV negative and on ART. Two
women were later excluded from being followed up
after data verification using PMTCT registers showed
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that the women were correctly recorded as HIV nega-
tive and that they were not on ART as reported on
the UAT form.
Health facility assessment
The purpose of the facility assessment was to determine
whether PMTCT HIV testing, data collection and record
keeping were standard across sites in order to ensure
availability of complete and valid PMTCT program data.
At each of the 53 facilities we administered a structured
questionnaire to one senior member of staff to obtain in-
formation on administrative ownership as defined by
whether facility was owned by government, religious af-
filiation (mission) or municipal owned, services offered
and HIV testing and referral practices. We collected
qualitative information on patient flow, HIV and syphilis
testing practices (including the managing and recording
of women who are known to be HIV positive at
booking). We also collected information on the availabil-
ity and completeness of key data elements such as age,
gravidity, parity and HIV status at booking. Although the
target number of sites was initially 54, one site, UAT sur-
veillance forms received from Karoi hospital did not
have PMTCT results nor samples for UAT testing and
was therefore excluded from further analysis.
Of the 53 sites, two facility assessments reports, for
Chimhanda and Plumtree were misplaced and could not
be traced between the facility and national office leaving
51 facilities in the health facility assessment analysis.
The unavailability of this information did not affect the
primary analysis of comparing HIV results from the
PMTCT program and results from the ANC register.
Data analysis
We used the UAT surveillance and PMTCT dataset from
the ANC register to generate frequency tables, pooled
site prevalence and individual analysis of HIV results
using STATA version 12.
Inclusion and exclusion for UAT and PMTCT datasets
(Fig. 1)
A total of 17,349 women were considered for analysis
in the by UAT surveillance and 17,150 women from
PMTCT register records at 53sites. The two datasets
were further cleaned and merged to provide a dataset
with 17, 478 records, of which a total of 16,782 (96.0 %)
where matched i.e. had both UAT and PMTCT program
result. A total of 696 records were excluded because they
did not appear either in the ANC or the UAT
surveillance datasets. Sites which had high numbers
of unmatched results in UAT surveillance included
Morgenster (103) and Silveira (111) and for PMTCT
Hauna (115) and Rusape (215). Although efforts were
made to recover samples from Hauna and Rusape were
not received at the NMRL and hence they were excluded
from some analysis. This resulted in different denomina-
tors for the different analysis.
Fig. 1 PMTCT program data and UAT surveillance data sets
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Comparison of prevalence HIV estimates derived from
program data and UAT surveillance
HIV prevalence estimates as recorded on the UAT
surveillance form were compared for each site. HIV
prevalence from program data was based on PMTCT
HIV test results as recorded on the UAT surveillance
data collection form by the site nurse. Women who were
recorded as known HIV-positive at booking in ANC
register data were considered HIV-positive for PMTCT
program data Pooled site and national HIV estimates
were calculated after excluding these missing results.
Individual-level agreement of PMTCT and UAT sur-
veillance HIV testing results was calculated among all
women with both test results as recorded on the UAT
surveillance form. These data were cross-tabulated to
calculate positive percent agreement (PPA) (same calcu-
lation as sensitivity) and negative percent agreement
(PNA) (the same calculation as specificity) of PMTCT
and UAT surveillance HIV testing. This gives a measure
of the proportion of individual cases giving results in
UAT and PMTCT as either both positive or negative.
Analysis of bias
Percent bias is defined by the positive or negative change
of the HIV prevalence among women who did and did
not accept PMTCT HIV testing (UAT) and those who
did accept PMTCT HIV testing. We used data captured
on the UAT surveillance form to analyse for selection
bias inherent in program data due to non-uptake of
PMTCT HIV testing. The HIV prevalence (according to
UAT surveillance testing) among women who did, and
did not, consent to PMTCT HIV testing (the population
captured by current surveillance methods) was com-
pared to the HIV prevalence among women who did
consent to PMTCT HIV testing (the population that
would have HIV test results available in a system of
surveillance based on program data). Percent bias was
calculated as the percent change (positive or negative)
from the total HIV prevalence (among both PMTCT
HIV testing accepters and non-acceptors) to the ob-
served HIV prevalence (PMTCT HIV testing acceptors
only). A total of 1, 176 (6.6 %) women who were known
HIV-positive at booking (according to the ANC register)
were excluded from this analysis as they would not be
expected to have the opportunity to accept or decline an
HIV test. Women with missing values for acceptance of
PMTCT HIV testing on the UAT surveillance form were
also excluded from the analysis.
Analysis of data quality
We analysed the completeness and concordance of
selected demographic variables of age, gravidity, parity,
HIV status at booking, ART medication status at book-
ing and PMTCT HIV result by comparing results
recorded on the UAT surveillance form with the results
in the ANC register data, using the bar-code label as a
temporary matching link for the purposes of a head to
head comparison of results. The analysis team did not
have access to personal identifying information. The
analysis team did not have access to personal identifying
information and bar codes were removed from registers
by site staff.
Analysis of site assessment data
Quantitative results of the sites assessments were
analyzed using simple descriptive analysis. We described
the frequency of optimal and sub-optimal PMTCT HIV
testing and data recording practices at surveillance senti-
nel sites. Of particular interest were non-standard prac-
tices, such as unavailability of onsite rapid HIV testing
that could negatively affect the uptake of PMTCT HIV
testing and the quality and completeness of program
data. We used a site assessment tool which had yes/no
response to elicit this information from onsite managers.
Data validation process
Each site had an onsite supervisor who performed
preliminary data quality and completeness checks. This
cadre received further support from support and su-
pervisory visits from higher levels. However final data
checks were conducted at time of receipt by the
National Surveillance Office and at point of data analysis.
Forms were checked for completeness and consistency.
Sites were notified of errors arising from their sites and re-
quested to improve data quality. However, because of the
constrained human resources during time of survey, this
was not always observed, hence the high number of miss-
ing forms, incomplete data and general poor data quality.
Ethical considerations
Approval to conduct the study was received from the
Medical Research Council of Zimbabwe and a non-
research determination was received from the Center for
Global Health (CGH), Centers for Disease Control and
Prevention (CDC) Atlanta.
We did not request consent to participate from the
pregnant women. By definition, unlinked anonymous
testing (UAT) surveillance does not inform women that
they would be tested for surveillance, therefore we did
not obtain individual consent from the women. How-
ever, because PMTCT is a priority intervention of the
Government of Zimbabwe Ministry of Health and Child
Care (MOHCC), all women are offered HIV testing and
counselling in the context of PMTCT program. The bar
code link was a temporary link which was removed and
delinked soon after the survey to avoid tracing back to
participants. Routinely site staff conducting the assess-
ment are expected to observe the highest level of
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Table 1 HIV prevalence estimates from UAT surveillance and PMTCT program data in ANC register
Site HIV prevalence according to UAT
surveillance testing (n = 17,349)
HIV prevalence according to
program dataa (n = 17,150)
p-value 95 % C.I (Testing difference between HIV prevalence
data according to UAT and PMTCT program data)
Banket 16.52 16.98 0.87 (−0.053; 0.062)
Beitbridge 22.36 22.46 0.97 (−0.063; 0.065)
Bindura 18.67 17.88 0.79 (−0.067; 0.051)
Binga 8.08 8.86 0.72 (−0.040; 0.051)
Chimhanda 9.57 10.54 0.68 (−0.037; 0.057)
Chinhoyi 14.16 14.11 0.99 (−0.053; 0.053)
Chiredzi 16.61 16.97 0.90 (−0.054; 0.061)
Chivi 12.04 13.72 0.52 (−0.035; 0.068)
Concession 15.62 17.05 0.62 (−0.043; 0.072)
Epworth 19.71 19.88 0.95 (−0.058; 0.062)
Filabusi 23.35 23.93 0.86 (−0.059; 0.071)
Glen View 10.21 9.31 0.70 (−0.054; 0.036)
Gokwe 11.34 12.75 0.59 (−0.037; 0.065)
Guruve 11.21 11.28 0.98 (−0.048; 0.049)
Gutu 15.88 16.77 0.76 (−0.047; 0.065)
Gwanda 25.61 30.6 0.16 (−0.019; 0.119)
Gweru 19.17 19.21 0.99 (−0.059; 0.060)
Hatcliffe 9.73 10.84 0.64 (−0.035; 0.057)
Hauna 10.31 11.32 0.74 (−0.048; 0.069)
Hwedza 17.26 17.31 0.99 (−0.057; 0.058)
Inyathi 20.67 23.51 0.38 (−0.036; 0.092)
Kadoma 14.98 16.39 0.63 (−0.043; 0.071)
Karanda 7.37 8.28 0.66 (−0.032; 0.050)
Kariba 14.58 15.09 0.85 (−0.049; 0.060)
Kuwadzana 11.69 11.66 0.99 (−0.037; 0.036)
Kwekwe 14.79 13.94 0.75 (−0.062; 0.045)
Mabvuku 12.36 16.31 0.36 (−0.039; 0.119)
Makumbe 19.33 19.41 0.98 (−0.061; 0.063)
Marondera 19.29 19.52 0.94 (−0.058; 0.062)
Masvingo 13.62 13.48 0.97 (−0.064; 0.061)
Murambinda 17.56 19.06 0.62 (−0.044; 0.074)
Murehwa 17.69 16.61 0.73 (−0.072; 0.051)
Musume 18.08 16.88 0.70 (−0.074; 0.050)
Mutambara 8.87 9.15 0.91 (−0.044; 0.050)
Mutoko 15.02 13.97 0.71 (−0.065; 0.044)
Mvuma 18.96 19.02 0.99 (−0.061; 0.062)
Ndanga 16.62 13.9 0.33 (−0.082; 0.027)
Neshuro 13.11 13.79 0.80 (−0.046; 0.059)
Nkayi 21.40 21.60 0.96 (−0.071; 0.075)
Nkulumane 17.11 18.01 0.69 (−0.035; 0.052)
Nyamandlovu 24.55 24.54 1.00 (−0.066; 0.066)
Nyanga 14.60 14.06 0.86 (−0.065; 0.054)
Plumtree 23.55 30.29 0.06 (0.002; 0.136)
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confidentiality as required by their professional codes of
ethics and provision of HIV testing services in PMTCT.
Additional safeguards were implemented through train-
ing of site staff and ensuring that all UAT surveillance
data collection forms were stored in locked drawers at
all sites and transferred to NMRL, where HIV test re-
sults were stored in a password protected database,
which only the laboratory survey administrator could
edit.
After data from the UAT surveillance form and the
ANC register had been matched for individual records
by the analysis team, the site staffs were requested to
remove the survey bar-code label from the ANC regis-
ters, except in the case of 12 women who had discrepant
results and required follow up. Ethical approval was re-
ceived from MRCZ to follow up these women and retest
to confirm status. The full report of this supplementary
activity of following 12 women with discordant results in
the 2012 ANC/PMTCT Assessment is available from the
Ministry of Health and Child Care, Zimbabwe.
Results
Comparison of UAT and PMTCT program data
The results for 53 sentinel sites showed that, among
17,349 women sampled during the UAT surveillance
period the pooled HIV prevalence was 15.8 % (95 % CI
15.3–16.4) with a range 7.37 % at Karanda to 25.61 % at
Gwanda, Among the 17,150 women participating in
PMTCT care compared to their information from the
ANC register, the pooled HIV prevalence was 16.3 %
(95 % CI 15.8–16.9) with a range of 8.28 % at St Alberts
and Karanda and 30.60 % at Gwanda (Table 1). At 37 of
the 53 sites (67.9 %) of the UAT surveillance result was
slightly lower than the PMTCT program result.
Among 17,349 women sampled during the UAT sur-
veillance period, 16,782 (96.0 %) had UAT surveillance
and PMTCT HIV test results as recorded on the UAT
surveillance data collection form. Individual level dis-
crepancies were observed between the onsite PMTCT
rapid HIV test results and ELISA tests results from the
NMRL as recorded on the UAT surveillance form. Dis-
crepant results were noted in 185 women who were HIV
positive according to PMTCT HIV test results as re-
corded on the UAT surveillance data collection form but
ELISA negative according to NMRL results. Similarly
another 185 samples were rapid HIV test negative
PMTCT HIV test results as recorded on the UAT sur-
veillance data collection form but ELISA positive at
NMRL. The pooled national PPA of PMTCT results to
UAT surveillance was 91.2 %, and the pooled national
PNA was 98.7 % (Table 2) for the 53 sites. Twenty-two
sites had individual level PPA below 91 % and nine sites
had a PNA below 98 %. These discrepant samples were
retested using DNA PCR by another laboratory. Of the
185 samples which were initially positive in PMTCT
only 89 remained positive and of the 185 initially nega-
tive samples only 173 were available for re-test and of
these 117 (67.6 %) tested HIV positive. Following retest
of the discrepant samples, the PPA of PMTCT data with
UAT was 94.5 % and PNA was 99.5 %.
Using results on the UAT surveillance form, the overall
uptake of PMTCT at the 53 sites was 95.2 %. The overall
percent bias introduced by PMTCT was −2.6 % (Table 3).
At least 1,176 women had an HIV positive result prior
to booking with current pregnancy. Among these
women, at least 705 (60 %) were already receiving ART,
but this did not include the 12 women whose PMTCT
program results and NMRL ELISA result were discord-
ant according to UAT form. The concordance rate for
HIV results in UAT and those in the PMTCT register
for women already on ART was 95.3 %. The overall me-
dian HIV prevalence (based on UAT surveillance testing)
among all women, including those who either accepted
or refused a PMTCT HIV test, was 12.9 % (Range
Table 1 HIV prevalence estimates from UAT surveillance and PMTCT program data in ANC register (Continued)
Rusape 21.93 18.64 0.53 (−0.136; 0.071)
Sadza 14.75 14.94 0.95 (−0.052; 0.056)
Sakubva 14.03 14.45 0.88 (−0.049; 0.057)
Shamva 15.48 14.37 0.69 (−0.065; 0.043)
Shurugwi 16.20 16.56 0.90 (−0.054; 0.062)
Silveira 12.70 14.48 0.59 (−0.046; 0.081)
St Alberts 8.33 8.28 0.98 (−0.044; 0.043)
St Mary’s 11.17 10.17 0.58 (−0.045; 0.025)
Victoria Falls 23.6 25.39 0.59 (−0.048; 0.083)
Zvishavane 21.3 23.24 0.55 (−0.044; 0.083)
Total 15.86 (95 % CI 15.32–16.41) 16.30 (95 % CI 15.74–16.85) 0.27 (−0.003; 0.012)
aIncludes women who received a positive PMTCT HIV test (as recorded on the UAT surveillance data collection form) and women who were known HIV positive at
booking (as recorded in the ANC register)
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Table 2 Individual-level agreement of PMTCT HIV testing resultsa and UAT surveillance (n = 16,782)
Site Number of
womenb
Percent HIV positive
according to UAT
surveillance testing
aPMTCT+/UAT + aPMTCT+/UAT - aPMTCT-/UAT + aPMTCT-/UAT - Positive
percent
agreement
Negative
percent
agreement
Banket 317 16.7 % 49 4 3 260 94.2 % 98.5 %
Beitbridge 305 17.0 % 50 2 2 249 96.2 % 99.2 %
Bindura 324 16.7 % 47 7 4 264 92.2 % 97.4 %
Binga 303 4.3 % 12 1 2 287 85.7 % 99.7 %
Chimhanda 313 8.9 % 27 1 3 277 90.0 % 99.6 %
Chinhoyi 322 11.5 % 32 5 2 280 94.1 % 98.2 %
Chiredzi 329 15.8 % 47 5 4 260 92.2 % 98.1 %
Chivi 315 9.8 % 28 3 3 269 90.3 % 98.9 %
Concession 291 12.7 % 35 2 3 249 92.1 % 99.2 %
Epworth 336 19.6 % 61 5 5 265 92.4 % 98.1 %
Filabusi 301 18.3 % 50 5 3 243 94.3 % 98.0 %
Glen View 333 10.2 % 29 5 2 296 93.5 % 98.3 %
Gokwe 302 10.3 % 29 2 5 266 85.3 % 99.3 %
Guruve 321 8.7 % 26 2 4 283 86.7 % 99.3 %
Gutu 320 12.5 % 39 1 3 277 92.9 % 99.6 %
Gwanda 279 18.6 % 49 3 8 218 86.0 % 98.6 %
Gweru 304 13.8 % 37 5 2 260 94.9 % 98.1 %
Hatcliffe 318 9.1 % 29 0 0 288 100.0 % 100.0 %
Hauna 208 8.7 % 18 0 1 189 94.7 % 100.0 %
Hwedza 311 10.3 % 31 1 1 277 96.9 % 99.6 %
Inyathi 315 17.1 % 51 3 8 249 86.4 % 98.8 %
Kadoma 302 12.3 % 34 3 8 254 81.0 % 98.8 %
Karanda 313 3.5 % 11 0 2 300 84.6 % 100.0 %
Kariba 308 11.4 % 34 1 3 267 91.9 % 99.6 %
Kuwadzana 590 11.4 % 64 3 3 519 95.5 % 99.4 %
Kwekwe 325 12.6 % 38 3 1 283 97.4 % 99.0 %
Mabvuku 326 3.4 % 11 0 3 75 78.6 % 100.0 %
Makumbe 297 17.5 % 46 6 3 236 93.9 % 97.5 %
Marondera 317 15.1 % 47 1 2 267 95.9 % 99.6 %
Masvingo 309 10.0 % 27 4 3 275 90.0 % 98.6 %
Murambinda 289 9.3 % 25 2 2 260 92.6 % 99.2 %
Murehwa 285 16.5 % 42 5 1 237 97.7 % 97.9 %
Musume 310 13.2 % 38 3 3 212 92.7 % 98.6 %
Mutambara 286 7.3 % 20 1 2 252 90.9 % 99.6 %
Mutoko 318 14.8 % 42 5 0 271 100.0 % 98.2 %
Mvuma 290 13.4 % 34 5 5 241 87.2 % 98.0 %
Ndanga 317 12.9 % 29 12 3 272 90.6 % 95.8 %
Neshuro 316 11.4 % 32 4 4 268 88.9 % 98.5 %
Nkayi 225 13.3 % 25 5 0 193 100.0 % 97.5 %
Nkulumane 557 13.6 % 74 2 2 475 97.4 % 99.6 %
Nyamandlovu 304 19.4 % 46 13 10 233 82.1 % 94.7 %
Nyanga 249 12.9 % 26 6 3 213 89.7 % 97.3 %
Plumtree 278 16.2 % 43 2 15 217 74.1 % 99.1 %
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4.0 %–19.4 %). In comparison, the median HIV prevalence
among women who did accept a PMTCT HIV test was
12.5 % (Range 3.4 %–19.5 %) resulting in an overall percent
bias of (−2.6 %). Eighteen sites had percent bias below
(−2.6 %), while fifteen sites reported a bias of 0.0 %. Table 3
Among the 16,782 women sampled from the ANC
register during the same time period as the UAT sur-
veillance period, percent completeness of data was as
follows: 99.9 % for age, 99.4 % for gravidity, 98.9 % for
parity, 86.9 % for HIV status at booking, 96.6 % for
already on ART, and 98.5 % for PMTCT HIV test result.
An analysis of recording practices showed that, among
HIV positive women who came to the clinic, 99.0 % were
consistently recorded in the ANC register as HIV positive.
Site assessment data was completed for 51 of the 53
sites (Table 4). All of these 51 sites offered onsite rapid
HIV testing in PMTCT sites. There were variations in
HIV testing and recording of previous HIV test history.
At least 11.8 % of sites offered an HIV test to women
who came to the site already knowing their status.
Among 43 sites (84.3 %) that did not offer a re-test to a
woman who came to the clinic knowing her result, 6
sites (14.0 %) did not record any result. Of the 51 sites, 9
sites (17.7 %) of the sites did not offer routine syphilis
tests to pregnant women. The assessment reported
stock-out of rapid HIV test kits at a third of the sites in
the year prior to this survey. Health staff at some facil-
ities reported that the national office had changed the
rapid testing algorithm from using Determine as the
screening test kit to First Response. This change was not
communicated to all sites. Following inadequate supplies
of the kit and challenges in interpreting the results, sites
reverted back to using Determinerapid HIV test kit.
Discussion
There was no statistically significant difference between
the pooled national HIV prevalence estimate obtained
from UAT surveillance period, 15.8 % (95 % CI
15.3;16.4) compared to PMTCT programme data esti-
mate of 16.3 % (95 % CI 15.8;16.9) during the same time
period in Zimbabwe in the 2012 assessment. Addition-
ally, there were no statistically significant variations
across the sites for pooled HIV prevalence and this is
consistent with studies elsewhere [14]. However, the
overall PPA of 91.2 % and PNA of 98.7 % suggest that
additional support for quality assurance of HIV testing is
required before Zimbabwe can transition to the use of
PMTCT programme data as a replacement for UAT sur-
veillance. Sentinel surveillance sites with low score on
the site assessment, poor PMTCT/NMRL testing con-
cordance, or poor routine data quality will be targeted
for support, but that all sites should benefit from mea-
sures to strengthen the quality of routine data, routine
testing and QA for onsite rapid HIV testing including
stock management and standardisation of data entry.
This assessment found a PMTCT uptake of 95.2 % and
overall selection bias in PMTCT program data of −2.6 %.
This finding means that non acceptance for an HIV test
among pregnant women did not introduce a significant
bias in the HIV prevalence estimates obtained from this
survey. When uptake of PMTCT testing is high, the
percent bias is lower and countries are in a favourable
position for transitioning if other critical criteria are met.
This finding is consistent with recent results from other
countries with high rates of uptake of PMTCT HIV
testing among ANC attendees [4–6]. Sites that reported
no difference between UAT surveillance and PMTCT pro-
gram data may signify high awareness of the benefits of
PMTCT resulting in clients choosing to accept an HIV
test rather than to opt-out.
The overall 91.2 % PPA and 98.7 % PNA between
UAT and PMTC program data are a little lower than de-
sirable for using PMTCT data for surveillance. Although
these are not strict targets, the WHO, CDC and other
Table 2 Individual-level agreement of PMTCT HIV testing resultsa and UAT surveillance (n = 16,782) (Continued)
Rusape 113 17.7 % 17 3 0 88 100.0 % 96.7 %
Sadza 319 11.9 % 36 2 4 277 90.0 % 99.3 %
Sakubva 340 14.1 % 46 2 4 284 92.0 % 99.3 %
Shamva 334 15.6 % 47 5 1 280 97.9 % 98.2 %
Shurugwi 296 12.8 % 30 8 9 233 76.9 % 96.7 %
Silveira 319 9.1 % 26 3 10 267 72.2 % 98.9 %
St Alberts 298 6.7 % 19 1 0 278 100.0 % 99.6 %
St Mary’s 600 11.2 % 59 8 2 531 96.7 % 98.5 %
Victoria Falls 282 14.2 % 39 1 2 240 95.1 % 99.6 %
Zvishavane 303 16.2 % 45 4 7 247 86.5 % 98.4 %
Total 16,782 12.6 % 1,928 185 185 14,051 91.2 % 98.7 %
aPMTCT HIV testing results as recorded on the UAT surveillance data collection form
bExcludes women with a missing PMTCT HIV test result on the UAT surveillance data collection form
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Table 3 Selection bias in non-acceptorsa of PMTCT HIV testingb
Site Number and HIV prevalence according to
surveillance testing among women who did
and did not accept PMTCT HIV testing (n = 16,719)
Number and HIV prevalence according to
surveillance testing among women who
accepted PMTCT HIV testing (n = 16,597)
Percent biasc
Banket 332 16.6 330 16.1 −3.1 %
Beitbridge 303 18.5 294 16.3 −11.6 %
Bindura 321 16.5 320 16.3 −1.6 %
Binga 316 5.4 304 4.3 −20.4 %
Chimhanda 319 9.4 315 9.2 −2.0 %
Chinhoyi 319 11.9 318 11.6 −2.3 %
Chiredzi 313 16.3 313 16.3 0.0 %
Chivi 310 9.7 307 9.8 0.9 %
Concession 319 13.2 315 12.4 −6.0 %
Epworth 339 19.5 339 19.5 0.0 %
Filabusi 308 19.2 303 17.8 −7.0 %
Glen View 333 10.2 333 10.2 0.0 %
Gokwe 325 9.9 325 9.9 0.0 %
Guruve 324 9.6 323 9.6 0.3 %
Gutu 320 11.9 319 11.6 −2.4 %
Gwanda 282 18.8 277 18.1 −3.9 %
Gweru 306 13.1 304 12.5 −4.4 %
Hatcliffe 330 8.5 329 8.2 −3.2 %
Hauna 215 8.4 214 7.9 −5.1 %
Hwedza 308 10.7 305 10.5 −2.1 %
Inyathi 306 16.7 303 16.5 −1.0 %
Kadoma 320 13.1 318 12.6 −4.2 %
Karanda 326 4.0 324 3.4 −14.8 %
Kariba 319 11.9 318 11.6 −2.3 %
Kuwadzana 595 11.6 595 11.6 0.0 %
Kwekwe 330 13.3 324 12.7 −5.1 %
Mabvuku 89 12.4 89 12.4 0.0 %
Makumbe 317 18.3 313 17.9 −2.2 %
Marondera 319 15.1 314 14.3 −4.8 %
Masvingo 317 11.0 316 10.8 −2.5 %
Murambinda 303 9.9 300 9.3 −5.8 %
Murehwa 290 15.5 290 15.5 0.0 %
Musume 272 16.9 272 16.9 0.0 %
Mutambara 285 7.4 285 7.4 0.0 %
Mutoko 330 14.2 330 14.2 0.0 %
Mvuma 300 13.3 298 12.8 −4.4 %
Ndanga 321 13.4 318 12.6 −6.1 %
Neshuro 315 11.1 315 11.1 0.0 %
Nkayi 237 17.3 219 13.7 −20.8 %
Nkulumane 551 13.6 551 13.6 0.0 %
Nyamandlovu 309 19.4 306 19.3 −0.7 %
Nyanga 262 12.2 261 11.9 −2.7 %
Plumtree 282 16.0 281 16.0 0.3 %
Gonese et al. BMC Infectious Diseases  (2016) 16:97 Page 10 of 13
health partners consider a PPA of 97.6 % and PNA of
99.7 % as desirable benchmarks for transitioning in
countries with HIV prevalence among pregnant women
of between 9 % and 16 % [2]. Studies conducted in
Kenya and Mozambique on the agreements between
routine HIV rapid testing and ELISA-based surveillance
found substantial disagreement between the two algo-
rithms, with PPA of PMTCT HIV testing and surveil-
lance HIV testing at 88.5 % and 75.9 % for Mozambique
and Kenya, respectively [4–6]. These discrepancies could
potentially be explained by the higher sensitivity of
ELISA test kits. The WHO has provided guidance to use
rapid HIV test kits in serial and to confirm results using
the Western Blot instead of using ELISA as this does
not eliminate false positives [15]. The improvements of
the PPA to 94.5 % and PNA to 99.5 % in this evaluation
suggest the need to ensure that onsite algorithms in-
clude both highly sensitive and specific rapid test kits in
order to improve accuracy of results. It is possible that
test results are affected by antiretroviral use. The effect
of low antibody as a result of antiretroviral therapy on
the accuracy of rapid HIV testing is currently not
documented. In Zimbabwe, variations in PPA and PNA
resulted in some sites having large differences between
HIV estimates based on UAT surveillance (NMRL ELISA
test) and those from routine PMTCT rapid HIV testing,
as observed at Beitbridge (−11.6 %), Binga (−20.4 %),
Karanda (−14.8 %) and Nkayi (−20.8 %). These results
show that UAT is proportionally lower than PMTCT
prevalence estimates. Assuming that the UAT testing re-
sult is accurate, a PPA of 91.2 % means that approxi-
mately 9 out of every 100 HIV positive women receive
an HIV negative result, and a PNA of 98.7 % translates
to 13 out of every 1,000 HIV negative women receiving
an HIV positive test result on the first visit. For women
receiving a false negative result, it is crucial for health
authorities to put in place follow-up testing policies that
would allow the individuals to receive the correct result in
future testing and have access to care. In the case of false
positive results, it is crucial to have a testing algorithm
which could include a follow on DNA-PCR and viral load
tests in order to avoid the negative impact of putting HIV
negative women on life-long treatment especially in the
era of option B+. When this assessment was implemented,
Zimbabwe was still working on revising testing algorithm
to take into account the need for viral load testing. Fur-
thermore, 22 of the 53 sites had individual level PPA
below 91 % and 9 sites had a PNA below 98 %. This study
highlighted the need for strengthening quality assurance
for onsite rapid HIV tests at the individual sites. The
National PMTCT program could consider a phased
approach in transitioning to use of PMTCT programme
data for sites with relatively high performance indicators.
The completeness of PMTCT data in ANC registers
was high for most key variables except for the women’s
reported HIV status at clinic entry. This was a significant
improvement from the completeness of ANC registers
reported in 2009 [12]. Previous assessments of the quality
of routinely collected ANC data for use in surveillance
have shown mixed results. Studies since 2000 in Botswana,
Kenya and Uganda reported significant data quality limita-
tions in ANC surveillance sites, including the lack of key
surveillance variables (such as HIV status at booking) in
ANC registers [10, 11, 16– 18]. However, a Botswana study
conducted in 2009 found a high level of completeness of
routine data in ANC surveillance sites [19].
The availability and high uptake of counselling and
rapid HIV testing in PMTCT setting are key in the tran-
sitioning from UAT surveillance to using PMTCT pro-
gram data. The assessment conducted in Zimbabwe in
2012 showed that while all sites offer onsite rapid HIV
testing; there are some elements that still require
Table 3 Selection bias in non-acceptorsa of PMTCT HIV testingb (Continued)
Rusape 109 18.4 108 18.5 0.9 %
Sadza 316 11.4 316 11.4 0.0 %
Sakubva 326 12.6 326 12.6 0.0 %
Shamva 334 15.6 331 15.4 −1.0 %
Shurugwi 286 12.9 284 12.7 −2.0 %
Silveira 313 9.3 312 9.0 −3.2 %
St Alberts 299 6.7 297 6.7 0.6 %
St Mary’s 599 11.2 599 11.2 0.0 %
Victoria Falls 291 14.1 289 13.8 −1.8 %
Zvishavane 309 15.9 308 15.6 −1.8 %
Total 16,719 12.9 % 16,597 12.5 % −2.6 %
aAcceptance of PMTCT HIV testing as recorded on the UAT surveillance data collection form
bExcluding those who were known HIV-positive at booking as recorded in the ANC register
cPercent bias is defined as the percent change, positive or negative, from the HIV prevalence among women who did and did not accept PMTCT HIV testing to
the HIV prevalence among women who accepted PMTCT HIV testing
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strengthening. The stock out of rapid HIV test kits re-
ported by at least 33.3 % of facilities in the last year point
to the need for strengthening supply chain management.
At least 17.7 % of sites also reported unavailability of rou-
tine syphilis test therefore showing absence of ancillary
tests in care and treatment settings. A closely related
problem is lack of quality assurance at facilities and that
sites may alter testing algorithms, leaving them without
either screening or confirmatory kits. Poor supply chain
management also results in biased results arising from
periods when test kits are available or unavailable [2].
Limitations
Both UAT surveillance and PMTCT register datasets were
characterized by missing or excluded records (Additional
file 1: Table S1 and Additional file 2: Table S2). Although
HIV test result in UAT surveillance was used as a refer-
ence point, it is conceivable that disagreement between
UAT and PMTCT testing could have potential for false
positives from using an EIA based algorithm.
Conclusions
There was no statistically significant difference between
pooled site level HIV prevalence from PMTCT data in the
ANC register and UAT surveillance. However, the overall
positive and negative percent agreements that were
slightly lower than the WHO benchmark suggest that
Zimbabwe should continue to reinforce the quality of
onsite HIV testing and program data collection in prepar-
ation for using PMTCT data for surveillance purposes.
However, sites that show good performance indicators
should be prioritised for transitioning. This assessment
highlights the need for Zimbabwe to strengthen the stan-
dardised rapid HIV testing algorithm, forecasting and
quantification of the requirement for rapid HIV and syph-
ilis test kits, and to put in place onsite quality assurance of
rapid HIV testing and record keeping practices in order to
transition to use PMTCT data for surveillance.
Additional files
Additional file 1: Table S1. Merged Data Set. (PDF 26 kb)
Additional file 2: Table S2. Missing samples. (DOC 117 kb)
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Table 4 Characteristics of sentinel surveillance sites as collected
on the site assessment questionnaire (n = 51)
Characteristic Response N (%)
Setting Urban 25 (49.0)
Rural 26 (51.0)
Ownership Government 33 (64.7)
Mission 8 (15.7)
City council 10 (19.6)
Private clinic 0 (0.0)
Other 0 (0.0)
Onsite Rapid testing Yes 51 (100.0)
No 0 (0.0)
PMTCT testing approach Opt out 47 (92.2)
Opt in 3 (5.9)
Missing 1 (1.9)
HIV test kits stock out in 2011 Yes 17 (33.3)
No 33 (64.7)
Among sites reporting test kits
stock out in 2011, the number
of distinct instances of stock
out
1–2 14 (100.0)
Missing 3 (17.6)
Syphilis testing done on site Yes 42 (82.4)
No 9 (17.7)
ANC register is a longitudinal
register
Yes 44 (86.3)
No 5 (9.8)
Missing 2 (3.9)
Women who are known
HIV-positive at booking are still
given an HIV test for PMTCT
Yes 6 (11.8)
No 43 (84.3)
Missing 2 (3.9)
Among those sites that do not
test a women who is known
HIV-positive at booking, what is
recorded in the HIV test result
field
Positive 18 (41.9)
Known positive/on ARV 15 (34.9)
Nothing recorded 6 (14.0)
Other 4 (9.3)
Information is recorded to
indicate that a pregnant
woman already knows she is
HIV positive
Yes 47 (92.2)
No 2 (3.9)
Missing 2 (3.9)
Among sites that do record the
status of previously known
positive, in what field is the
information recorded
HIV status before booking 16 (34.0)
Already on ART 2 (4.3)
HIV test result in ANC 11 (23.4)
Notes/comments 7 (14.9)
Other 1 (2.1)
Missing 9 (19.1)
What is recorded for “HIV test
result” is a woman refuses an
HIV test
Not applicable 1 (1.96)
Refused 31 (60.8)
Nothing recorded 2 (3.9)
Other 17 (33.3)
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